GLMD logo

Galmed Pharmaceuticals (GLMD) Retained Earnings

Annual Retained Earnings

-$192.95 M
-$6.91 M-3.72%

December 31, 2023


Summary


Performance

GLMD Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGLMDbalance sheetmetrics:

Quarterly Retained Earnings

-$197.26 M
-$1.91 M-0.98%

September 30, 2024


Summary


Performance

GLMD Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGLMDbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

GLMD Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-3.7%-3.3%
3 y3 years-42.2%-3.3%
5 y5 years-123.1%-3.3%

GLMD Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-14.7%at low-17.3%at low
5 y5-year-80.4%at low-84.5%at low
alltimeall time-1799.7%at low-613.6%at low

Galmed Pharmaceuticals Retained Earnings History

DateAnnualQuarterly
Sep 2024
-
-$197.26 M(+1.0%)
Jun 2024
-
-$195.35 M(+0.6%)
Mar 2024
-
-$194.23 M(+0.7%)
Dec 2023
-$192.95 M(+3.7%)
-$192.95 M(+1.1%)
Sep 2023
-
-$190.94 M(+0.8%)
Jun 2023
-
-$189.46 M(+0.8%)
Mar 2023
-
-$187.87 M(+1.0%)
Dec 2022
-$186.04 M(+10.6%)
-$186.04 M(+1.4%)
Sep 2022
-
-$183.40 M(+3.0%)
Jun 2022
-
-$178.05 M(+2.1%)
Mar 2022
-
-$174.32 M(+3.7%)
Dec 2021
-$168.17 M(+23.9%)
-$168.17 M(+4.6%)
Sep 2021
-
-$160.72 M(+5.0%)
Jun 2021
-
-$153.01 M(+5.8%)
Mar 2021
-
-$144.61 M(+6.6%)
Dec 2020
-$135.71 M(+26.9%)
-$135.71 M(+8.2%)
Sep 2020
-
-$125.43 M(+5.8%)
Jun 2020
-
-$118.53 M(+4.9%)
Mar 2020
-
-$113.00 M(+5.7%)
Dec 2019
-$106.94 M
-$106.94 M(+8.4%)
Sep 2019
-
-$98.65 M(+4.8%)
Jun 2019
-
-$94.14 M(+4.6%)
DateAnnualQuarterly
Mar 2019
-
-$89.97 M(+4.0%)
Dec 2018
-$86.47 M(+12.9%)
-$86.47 M(+4.5%)
Sep 2018
-
-$82.77 M(+1.2%)
Jun 2018
-
-$81.81 M(+3.4%)
Mar 2018
-
-$79.13 M(+3.3%)
Dec 2017
-$76.62 M(+19.1%)
-$76.62 M(+5.0%)
Sep 2017
-
-$72.97 M(+4.0%)
Jun 2017
-
-$70.17 M(+4.0%)
Mar 2017
-
-$67.48 M(+4.9%)
Dec 2016
-$64.32 M(+35.8%)
-$64.32 M(+8.1%)
Sep 2016
-
-$59.49 M(+6.9%)
Jun 2016
-
-$55.66 M(+8.4%)
Mar 2016
-
-$51.35 M(+8.4%)
Dec 2015
-$47.37 M(+28.9%)
-$47.37 M(+7.3%)
Sep 2015
-
-$44.16 M(+6.3%)
Jun 2015
-
-$41.56 M(+6.0%)
Mar 2015
-
-$39.21 M(+6.7%)
Dec 2014
-$36.74 M(+32.9%)
-$36.74 M(+5.7%)
Sep 2014
-
-$34.77 M(+10.2%)
Jun 2014
-
-$31.56 M(+5.9%)
Mar 2014
-
-$29.80 M(+7.8%)
Dec 2013
-$27.64 M(+172.1%)
-$27.64 M
Dec 2012
-$10.16 M
-

FAQ

  • What is Galmed Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for Galmed Pharmaceuticals?
  • What is Galmed Pharmaceuticals annual retained earnings year-on-year change?
  • What is Galmed Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Galmed Pharmaceuticals?
  • What is Galmed Pharmaceuticals quarterly retained earnings year-on-year change?

What is Galmed Pharmaceuticals annual retained earnings?

The current annual retained earnings of GLMD is -$192.95 M

What is the all time high annual retained earnings for Galmed Pharmaceuticals?

Galmed Pharmaceuticals all-time high annual retained earnings is -$10.16 M

What is Galmed Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, GLMD annual retained earnings has changed by -$6.91 M (-3.72%)

What is Galmed Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of GLMD is -$197.26 M

What is the all time high quarterly retained earnings for Galmed Pharmaceuticals?

Galmed Pharmaceuticals all-time high quarterly retained earnings is -$27.64 M

What is Galmed Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, GLMD quarterly retained earnings has changed by -$6.32 M (-3.31%)